Absence of somatic SQSTM1 mutations in Paget's disease of bone.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2008-1140PMID 18984666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequestosome 1 (SQSTM1) Mutations in Paget’s Disease of Bone from the United States

  2008cited by this paper
• Identification of a Major Locus for Paget's Disease on Chromosome 10p13 in Families of British Descent

  2007cited by this paper
• Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.

  2007cited by this paper
• p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

  2006cited by this paper
• Sequestosome 1: Mutation Frequencies, Haplotypes, and Phenotypes in Familial Paget's Disease of Bone

  2006cited by this paper
• Cancer genetics: colorectal cancer as a model

  2006cited by this paper
• A Novel Mutation (K378X) in the Sequestosome 1 Gene Associated With Increased NF‐κB Signaling and Paget's Disease of Bone With a Severe Phenotype

  2006cited by this paper
• Differential Gene Expression in Cultured Osteoblasts and Bone Marrow Stromal Cells From Patients With Paget's Disease of Bone

  2006cited by this paper
• SQSTM1 and Paget’s Disease of Bone

  2004cited by this paper
• Paget’s Disease of Bone in New Zealand: Continued Decline in Disease Severity

  2004cited by this paper
• Loss of Ubiquitin‐Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations

  2004cited by this paper
• The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis.

  2004cited by this paper
• Sequence Analysis of Measles Virus Nucleocapsid Transcripts in Patients with Paget's Disease

  2002cited by this paper
• Pathophysiology and Treatment of Paget's Disease of Bone

  1991cited by this paper

• Latest Developments in Paget's Disease of Bone.

  2025cites this paper
• Update on the pathogenesis and genetics of Paget’s disease of bone

  2022cites this paper
• Recent advances in understanding and managing Paget’s disease

  2019cites this paper
• Chapter 25 – Genetics of Paget’s Disease of Bone

  2018cites this paper
• Paget's disease of bone.

  2017cites this paper
• Investigating the role of optineurin in bone biology and Paget's disease of bone

  2016cites this paper
• Paget's Disease in an Omani: Long-term Improvement Following a Single Injection of Zoledronic Acid.

  2016cites this paper
• Genetics of Paget's disease of bone.

  2015cites this paper
• Paget's disease of bone—genetic and environmental factors

  2015cites this paper
• Detection of SQSTM1/P392L post-zygotic mutations in Paget’s disease of bone

  2014cites this paper
• Genetics of Paget’s Disease of Bone

  2014cites this paper
• Paget's disease of bone.

  2014cites this paper
• Chapter 19 – Genetics of Paget’s Disease of Bone

  2013cites this paper
• New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.

  2013cites this paper
• Paget's disease of bone: evidence for complex pathogenetic interactions.

  2012cites this paper
• Pathogenesis of Paget Disease of Bone

  2012cites this paper
• Genetics of bone diseases: Paget's disease, fibrous dysplasia, osteopetrosis, and osteogenesis imperfecta.

  2011cites this paper
• Paget's disease of bone: an update

  2011cites this paper
• A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.

  2011cites this paper
• SQSTM1 gene analysis and gene‐environment interaction in Paget's disease of bone

  2010cites this paper
• Génétique des maladies osseuses

  2010cites this paper
• Genetic aspects of the Paget’s disease of bone: concerns on the introduction of DNA‐based tests in the clinical practice. Advantages and disadvantages of its application

  2010cites this paper
• The role of genes in the pathogenesis of Paget's disease of bone

  2010cites this paper
• Dickkopf-1 as a potential therapeutic target in Paget's disease of bone

  2010cites this paper
• Paget's disease of bone: there's more than the affected skeletal – a clinical review and suggestions for the clinical practice

  2010cites this paper
• Bone: Do all Paget disease risk genes incriminate the osteoclast?

  2010cites this paper
• New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis

  2010cites this paper
• Genetic aspects of the Paget's disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application.

  2010cites this paper
• Paget’s disease of bone: a review of epidemiology, pathophysiology and management

  2009cites this paper
• Paget's Disease of Bone

  2009cites this paper
• Paget’s disease of bone

  2009cites this paper
• Involvement of the osteoblast in Paget's disease of bone.

  2009cites this paper
• Recent advances in understanding the molecular basis of Paget disease of bone

  2009cites this paper
• Pathogenesis of Paget's disease of bone

  2002cites this paper